Less Ads, More Data, More Tools Register for FREE

Pin to quick picksConcurrent Technologies Regulatory News (CNC)

Share Price Information for Concurrent Technologies (CNC)

Share Price is delayed by 15 minutes
Get Live Data
250.00    0.00 (0.00%)
Bid:
245.00
Ask:
255.00
Spread: 10.00 (4.082%)
Market Cap: £227.11m
CNC Live PriceLast checked at - London Stock Exchange

Intraday Concurrent Technologies Share Chart

Product Launch

6 Jan 2011 07:00

RNS Number : 9885Y
Concurrent Technologies PLC
06 January 2011
 



Concurrent Technologies Plc

 

Product Launch

 

Two New Products using latest 2nd generation Intel® Core™ processors

Concurrent Technologies Plc (the "Company"), a world leading specialist in the design and manufacture of high-end embedded computer products, is pleased to announce the launch of two new high performance VME/VXS and VPX processor boards. Significantly, both new products utilize the very latest quad-core or dual-core 2nd generation Intel®Core™ processors announced by Intel®in the first week of January 2011. These processors offer enhanced processing and graphic capabilities, resulting in virtually double the graphics performance of previous generations.

 

Following the Company's strategy to develop and release products using the most advanced technology as soon as it is available, both processor boards provide ideal upgrade paths to current products, offering existing and new customers the opportunity to upgrade their systems to the latest processing technology.

 

Both of today's products have been developed to provide superior performance and features over previous generations of boards and are particularly aimed at the defence and security market segments. They are the first of a planned family of boards using this latest technology, with a further two products planned for launch within the first half of 2011. Extended temperature and ruggedized variants of these boards will be available in the coming months.

 

Glen Fawcett, Managing Director, Concurrent Technologies Plc, commented:

 

"I am delighted that we have again been able to demonstrate that our dedicated close partnership with Intel® enables us to release these two new advanced products immediately following the technology release from Intel®. Our customers demand the very latest processing technology for their applications, and this platform delivers significant improvements over the previous generation."

"This release shows our continuing commitment to introducing leading edge embedded processing technology to the market as early as possible, which is essential for us to remain as a world-leading high end developer."

 

6th January 2011

 

Enquiries:

 

Concurrent Technologies Plc Glen Fawcett, Managing Director +44 (0)1206 752 626

 

NexFin (Financial PR) Nicholas Nelson +44 (0)7921 522920

 

Cenkos Securities Plc (NOMAD)

Ken Fleming +44 (0)131 220 6939

Beth McKiernan +44 (0)131 220 9778

 

All trademarks, registered trademarks and trade names used in this announcement are the property of their respective owners.

 

Note to Editors:

 

Concurrent Technologies Plc develops and manufactures high-end embedded computer products for use in a wide range of high performance applications within the telecommunications, defence, security, telemetry, scientific and aerospace markets. Using Intel® processors, including the latest 2nd generation Intel® Core™, Intel® Core™ i7 processors, Intel® Xeon®, Atom™ and Core™ 2 dual-core processors, the Company offers a wide range of computer products which are designed to be compliant with the most stringent industry specifications including those for products used in extremely harsh environments.

 

For more information on Concurrent and its products please visit http://www.cct.co.uk 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
PRLBAMRTMBIMBPB
Date   Source Headline
27th Dec 20137:00 amRNSTrading Update
13th Dec 20134:31 pmRNSProduct Launch
6th Dec 20131:35 pmRNSHolding(s) in Company
28th Nov 201311:31 amRNSHolding(s) in Company
1st Nov 20133:45 pmRNSTotal Voting Rights
24th Oct 20134:13 pmRNSProduct Launch
23rd Oct 20132:56 pmRNSTransaction in Own Shares
8th Oct 20132:35 pmRNSProduct Launch
4th Oct 20135:01 pmRNSTransaction in Own Shares
1st Oct 20133:13 pmRNSTotal Voting Rights
25th Sep 20132:38 pmRNSTransaction in Own Shares
4th Sep 20132:42 pmRNSTransaction in Own Shares
22nd Aug 20137:00 amRNSInterim Results
16th Aug 20133:58 pmRNSNotice of Results
12th Aug 201312:40 pmRNSTrading Update
21st Jun 201312:20 pmRNSHolding(s) in Company
4th Jun 20137:00 amRNSProduct Launch
28th May 20132:00 pmRNSAGM Statement
24th May 20133:10 pmRNSProduct Launch
13th May 20134:25 pmRNSProduct Launch
24th Apr 20135:01 pmRNSDistribution of Annual Report and Accounts
9th Apr 20137:00 amRNSFinal Results
19th Mar 20134:25 pmRNSNotice of Results & Dividend
1st Mar 20132:15 pmRNSProduct Launch
24th Dec 20127:00 amRNSTrading Update
21st Dec 20121:17 pmRNSProduct Launch
21st Nov 20123:27 pmRNSHolding(s) in Company
5th Nov 201212:25 pmRNSProduct Launch
31st Oct 201210:32 amRNSTotal Voting Rights
19th Sep 20125:28 pmRNSHolding(s) in Company
5th Sep 20127:00 amRNSInterim Results
29th Aug 20125:36 pmRNSNotice of Results
22nd Jun 20124:42 pmRNSTotal Voting Rights
14th Jun 20123:50 pmRNSTransaction in Own Shares
7th Jun 20127:00 amRNSProduct Launch
31st May 20123:30 pmRNSTotal Voting Rights
29th May 20121:30 pmRNSAGM Statement
22nd May 201212:21 pmRNSTreasury Shares
8th May 20127:00 amRNSDistribution of Annual Report and Accounts
4th May 20123:53 pmRNSHolding(s) in Company
17th Apr 20123:51 pmRNSHolding(s) in Company
12th Apr 201211:44 amRNSHolding(s) in Company
26th Mar 20127:00 amRNSPreliminary Results
16th Mar 20123:17 pmRNSNotice of Results
6th Mar 20121:45 pmRNSDividend Declaration
16th Jan 20127:00 amRNSProduct Launch
29th Dec 20115:46 pmRNSDirector/PDMR Shareholding
22nd Dec 201112:41 pmRNSTrading Statement
9th Dec 20114:53 pmRNSProduct Launch
2nd Dec 201111:03 amRNSProduct Launch

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.